LY335979 (Zosuquidar 3HCL)

• Description:

  Pgp (P-glycoprotein) inhibitor

• Product Name Alternative:

  (R)-1-(4-((1aR,6s,10bS)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c][7]annulen-6-yl)piperazin-1-yl)-3-(quinolin-5-yloxy)propan-2-ol trihydrochloride

• Sequence:

  RS 33295-198; Zosuquidar trihydrochloride; LY335979; LY-335979

• Field of Research:

  Membrane Transporter Ion Channel P-gp

• Purity:

  0.9884

• Form:

  A solid

• Solubility:

  insoluble in EtOH; ≥17.1 mg/mL in DMSO; ≥31.9 mg/mL in H2O

• Smiles:

  FC1([C@H](C2=CC=CC=C23)[C@@H]1C4=CC=CC=C4[C@H]3N5CCN(C[C@H](COC6=C7C(N=CC=C7)=CC=C6)O)CC5)F.Cl.Cl.Cl

• Molecular Formula:

  C32H34Cl3F2N3O2

• Molecular Weight:

  637.0

• Shipping Conditions:

  Blue ice

• Storage Conditions:

  Store at -20°C.

• CAS Number:

  167465-36-3